hepatitis B – Página 4 – Fundacion Investigaciones Biomédicas

Distribution of the predominant hepatitis B virus precore variants in hepatitis B e antigen-positive children and their effect on treatment response.

Cabrerizo M, Bartolomé J, Ruíz-Moreno M, Otero M, López-Alcorocho JM,Carreño V. Pediatric Res1996; 39: 980-984.

Fecha 28 Jun 1996
Por Luis
En Publicaciones

Ver Abstract

Factors predictive of response to interferon therapy in children with chronic hepatitis B.

Ruíz-Moreno M, Camps T, Jiménez J, López R, Castillo I, Bartolomé J,Carreño V. J Hepatol 1995; 22: 540-544.

Fecha 19 Sep 1995
Por Luis
En Publicaciones

Ver Abstract

Hepatitis B and D genomes in hepatitis B surface antigen negative patients with chronic hepatitis C

González S, Navas S, Madejón A, Bartolomé J, Castillo I, Moraleda G, Martín J, Marriott E, Herrero M,Carreño V. J Med Virol 1995; 45: 168-173.

Fecha 19 Mar 1995
Por Luis
En Publicaciones

Ver Abstract

Analysis of hepatitis B virus precore variants in hepatitis B e antibody-positive patients treated with prednisone plus interferon.

López-Alcorocho JM, Cabrerizo M, Bartolomé J, Cotonat T,Carreño V. J Viral Hepatitis 1995; 2: 279-284.

Fecha 16 Mar 1995
Por Luis
En Publicaciones

Ver Abstract

Comparative study of three doses of interferon-alpha 2a in chronic active hepatitis B

Thomas HC, Lok ASF,Carreño V, Farrell G, Tanno H, Pérez V, Dusheiko GM, Cooksley G, Ryff JC and the International Hepatitis Trial Group. J Viral Hepatitis 1994; 1: 139-148.

Fecha 24 Oct 1994
Por Luis
En Publicaciones

Ver Abstract

Analysis of hepatitis B precore region in serum and liver of chronic hepatitis B virus carriers

López-Alcorocho JM, Moraleda G, Bartolomé J, Castillo I, Cotonat T, Aguilar J, Ortega E, Pons JA, Salmerón J, Vázquez-Iglesias JL,Carreño V. J Hepatol 1994; 21: 353-360.

Fecha 17 Oct 1994
Por Luis
En Publicaciones

Ver Abstract

Changes in cytokine production during therapy with granulocyte-macrophage colony-stimulating factor in patients with chronic hepatitis B.

Martín J, Quiroga JA, Bosch O,Carreño V. Hepatology 1994; 20: 1156-1161.

Fecha 11 May 1994
Por Luis
En Publicaciones

Ver Abstract

The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials.

Krogsgaards K, Bindslev N, Christensen E, Craxi A, Schlichting P, Schalm S,Carreño V, Trepo C, Gerken G, Thomas HC, Andersen PK, Ring-Larsen H and the European Concerted Action on Viral Hepatitis (Eurohep). J Hepatol 1994; 21: 646-655.

Fecha 19 Ene 1994
Por Luis
En Publicaciones

Ver Abstract

Long-term effect of interferon therapy in chronic hepatitis B

Carreño V, Bartolomé J, Castillo I. J Hepatol 1994; 20: 431-435.

Fecha 14 Ene 1994
Por Luis
En Publicaciones

Ver Abstract

Levamisole and interferon in children with chronic hepatitis B

Ruiz-Moreno M, García R, Rúa MJ, Serrano B, Moraleda G, Feijoo E, Bartolomé J, Ortiz F, Castillo I,Carreño V. Hepatology 1993; 18: 264-269.

Fecha 18 Dic 1993
Por Luis
En Publicaciones

Ver Abstract

Alpha and gamma interferon versus alpha interferon alone in chronic hepatitis B. A randomized controlled trial.

Carreño V, Moreno A, Galiana F, Bartolomé J. J Hepatol 1993; 17: 321-325.

Fecha 16 Sep 1993
Por Luis
En Publicaciones

Ver Abstract

Pilot study of recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of chronic hepatitis B

Martín J, Bosch O, Moraleda G, Bartolomé J, Quiroga JA,Carreño V. Hepatology 1993; 18: 775-780.

Fecha 17 Mar 1993
Por Luis
En Publicaciones

Ver Abstract

Etiqueta : hepatitis B